Picture of Shanghai Junshi Biosciences logo

1877 — Shanghai Junshi Biosciences News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Brief: Shanghai Junshi Biosciences Announces Receipt Of Positive Opinion For Toripalimab

July 26 (Reuters) - Shanghai Junshi Biosciences Co Ltd
 688180.SS :
    * RECEIPT OF POSITIVE OPINION FROM COMMITTEE FOR MEDICINAL
PRODUCTS FOR HUMAN USE OF EMA FOR TORIPALIMAB


Further company coverage:  688180.SS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shanghai Junshi Biosciences

See all news